Francine Kaufman - 11 Jun 2021 Form 4 Insider Report for Senseonics Holdings, Inc. (SENS)

Role: Chief Medical Officer, Director
Signature: /s/ Darren K. DeStefano, Attorney-in-Fact
Issuer symbol: SENS
Transactions as of: 11 Jun 2021
Net transactions value: -$186,300
Form type: 4
Filing time: 15 Jun 2021, 16:56:17 UTC
Previous filing: 08 Jun 2021
Next filing: 16 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SENS	Common Stock	Options Exercise	$64,212	+20,916	+1.9%	$3.07	1,120,504	11 Jun 2021	Direct	F1
transaction	SENS	Common Stock	Sale	$250,512	-62,628	-5.6%	$4.00^*	1,057,876	11 Jun 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SENS	Stock Option (right to buy)	Options Exercise	$0	+20,916	+4.1%	$0.000000	529,084	11 Jun 2021	Common Stock	20,916	$3.07	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the record holder of the securities on March 15, 2021.
F2	One-fourth of the shares vested on March 4, 2020, with the remaining shares vesting in 36 equal installments at the end of the calendar month for each month after March 4, 2020, subject to the reporting person's continuous service with the issuer as of the applicable vesting date.